EDGAR Filing Documents for 0001140361-20-003728

Form 8-K - Current report:

SEC Accession No. 0001140361-20-003728

Filing Date

2020-02-20

Accepted

2020-02-20 17:20:31

Documents

Period of Report

2020-02-18

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	form8k.htm	8-K	27104
2	EXHIBIT 4.1	ex4_1.htm	EX-4.1	18864
3	EXHIBIT 4.2	ex4_2.htm	EX-4.2	555181
4		image0.jpg	GRAPHIC	86517
5		image1.jpg	GRAPHIC	97661
6		image2.jpg	GRAPHIC	74927
7		image3.jpg	GRAPHIC	74969
8		image4.jpg	GRAPHIC	84948
9		image5.jpg	GRAPHIC	83635
	Complete submission text file	0001140361-20-003728.txt		1294635

Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118

Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100

ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)